サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：関節痛注射の世界市場 (2022年～2031年)：関節タイプ (膝&足首・股関節・肩&肘・脊椎椎間関節・その他) 別の産業分析・規模・シェア・成長・動向・予測
市場調査レポート
商品コード
1140652

関節痛注射の世界市場 (2022年～2031年)：関節タイプ (膝&足首・股関節・肩&肘・脊椎椎間関節・その他) 別の産業分析・規模・シェア・成長・動向・予測

Joint Pain Injections Market (Joint Type: Knee & Ankle, Hip Joint, Shoulder & Elbow, Facet Joints of Spine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
出版日: | 発行: Transparency Market Research | ページ情報: 英文 190 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
関節痛注射の世界市場 (2022年～2031年)：関節タイプ (膝&足首・股関節・肩&肘・脊椎椎間関節・その他) 別の産業分析・規模・シェア・成長・動向・予測
出版日: 2022年08月04日
発行: Transparency Market Research
ページ情報: 英文 190 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の関節痛注射薬の市場を調査し、市場概要、市場成長への各種影響因子の分析、技術動向、法規制シナリオ、パイプラインの分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 序文

第2章 前提・調査手法

第3章 エグゼクティブサマリー：世界の関節痛注射市場

第4章 市場概要

  • 概要
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • 世界の関節痛注射市場の分析・予測

第5章 主な洞察

  • 技術の進歩
  • 規制シナリオ：地域/世界別
  • パイプライン分析
  • 世界の主要国における疾患の有病率と発生率
  • COVID-19：影響分析

第6章 世界の関節痛注射市場の分析・予測：関節タイプ別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場予測
    • 膝・足首
    • 股関節
    • 肩・肘
    • 脊椎椎間関節
    • その他
  • 市場の魅力

第7章 世界の関節痛注射市場の分析・予測：注射タイプ別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場予測
    • コルチコステロイド注射
    • ヒアルロン酸注射
    • その他
  • 市場の魅力

第8章 世界の関節痛注射市場の分析・予測：流通チャネル別

  • イントロダクション・定義
  • 主な調査結果/展開
  • 市場予測
    • 病院薬局
    • オンライン薬局
    • 小売薬局
  • 市場の魅力

第9章 世界の関節痛注射市場の分析・予測：地域別

  • 主な調査結果
  • 市場予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力

第10章 北米の関節痛注射市場の分析・予測

第11章 欧州の関節痛注射市場の分析・予測

第12章 アジア太平洋の関節痛注射市場の分析・予測

第13章 ラテンアメリカの関節痛注射市場の分析・予測

第14章 中東およびアフリカの関節痛注射市場の分析・予測

第15章 競合情勢

  • 主要企業の競合マトリックス
  • 市場シェア分析：企業別
  • 企業プロファイル
    • Pfizer, Inc.
    • Anika Therapeutics, Inc.
    • Bioventus
    • Eli Lilly and Company
    • Ferring BV
    • Pacira BioSciences, Inc.（Flexion Therapeutics）
    • Sanofi
    • Seikagaku Corporation
    • Zimmer Biomet
図表

List of Tables

  • Table 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 02: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017-2031
  • Table 03: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 04: Global Joint Pain Injection Market Value (US$ Mn) Forecast, by Region , 2017-2031
  • Table 05: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country, 2017-2031
  • Table 06: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 07: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017-2031
  • Table 08: North America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 09: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 10: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 11: Europe Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 12: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 13: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 14: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017-2031
  • Table 15: Asia Pacific Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 16: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 18: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017-2031
  • Table 19: Latin America Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 20: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 21: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Joint Type, 2017-2031
  • Table 22: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Injection Type, 2017-2031
  • Table 23: Middle East & Africa Joint Pain Injection Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031

List of Figures

  • Figure 01: Global Joint Pain Injection Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2021
  • Figure 03: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2021
  • Figure 04: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2021
  • Figure 05: Global Joint Pain Injection Market Value Share (%), by Region, 2021
  • Figure 06: Global Joint Pain Injection Market Value Share (%), by Joint Type, 2017 and 2031
  • Figure 07: Global Joint Pain Injection Market Value Share (%), by Injection Type, 2017 and 2031
  • Figure 08: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Injection Type, 2017-2031
  • Figure 09: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Knee & Ankle 2017-2031
  • Figure 10: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hip Joint, 2017-2031
  • Figure 11: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Shoulder & Elbow, 2017-2031
  • Figure 12: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Facet Joints of Spine, 2017-2031
  • Figure 13: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 14: Global Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2021-2031
  • Figure 15: Global Joint Pain Injection Market Attractiveness Analysis, by Injection Type, 2021-2031
  • Figure 16: Global Joint Pain Injection Market Attractiveness Analysis, by Devices, 2021-2031
  • Figure 17: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031
  • Figure 18: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2021-2031
  • Figure 19: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corticosteroid Injections, 2017-2031
  • Figure 20: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hyaluronic Acid Injections, 2017-2031
  • Figure 21: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
  • Figure 22: Global Joint Pain Injection Market Value Share (%), by Distribution Channel, 2017 and 2031
  • Figure 23: Global Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel
  • Figure 24: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2017-2031
  • Figure 25: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2017-2031
  • Figure 26: Global Joint Pain Injection Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2017-2031
  • Figure 27: Global Joint Pain Injection Market Value Share Analysis, by Region, 2017 and 20231
  • Figure 28: Global Joint Pain Injection Market Attractiveness Analysis, by Region, 2021-2031
  • Figure 29: North America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 30: North America Joint Pain Injection Market Value Share (%), by Country, 2017 and 2031
  • Figure 31: North America Joint Pain Injection Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 32: North America Joint Pain Injection Market Value Share, by Joint Type, 2017and 2031
  • Figure 33: North America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022-2031
  • Figure 34: North America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
  • Figure 35: North America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 36: Europe Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 37: Europe Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017and 2031
  • Figure 38: Europe Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 39: Europe Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
  • Figure 40: Europe Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022-2031
  • Figure 41: Europe Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
  • Figure 42: Europe Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 43: Asia Pacific Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 44: Asia Pacific Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 45: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 46: Asia Pacific Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
  • Figure 47: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022-2031
  • Figure 48: Asia Pacific Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
  • Figure 49: Asia Pacific Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 50: Latin America Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 51: Latin America Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 52: Latin America Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 53: Latin America Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
  • Figure 54: Latin America Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2017-2031
  • Figure 55: Latin America Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
  • Figure 56: Latin America Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2017-2031
  • Figure 57: Middle East & Africa Joint Pain Injection Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
  • Figure 58: Middle East & Africa Joint Pain Injection Market Value Share (%), by Country/Sub-region, 2017 and 2031
  • Figure 59: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 60: Middle East & Africa Joint Pain Injection Market Value Share, by Joint Type, 2017 and 2031
  • Figure 61: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Joint Type, 2022-2031
  • Figure 62: Middle East & Africa Joint Pain Injection Market Value Share, by Distribution Channel, 2017 and 2031
  • Figure 63: Middle East & Africa Joint Pain Injection Market Attractiveness Analysis, by Distribution Channel, 2022-2031
目次
Product Code: TMRGL47664

The report provides revenue of the global joint pain injections market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global joint pain injections market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the joint pain injections market.

The report delves into the competitive landscape of the global joint pain injections market. Key players operating in the global joint pain injections market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global joint pain injections market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Joint Pain Injections Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Joint Pain Injections Market Analysis and Forecast, 2017-2031
    • 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

  • 5.1. Technological Advancements
  • 5.2. Regulatory Scenario by Region/globally
  • 5.3. Pipeline Analysis
  • 5.4. Disease Prevalence & Incidence Rate globally with key countries
  • 5.5. Covid-19 Impact Analysis

6. Global Joint Pain Injections Market Analysis and Forecast, by Joint Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Joint Type, 2017-2031
    • 6.3.1. Knee & Ankle
    • 6.3.2. Hip Joint
    • 6.3.3. Shoulder & Elbow
    • 6.3.4. Facet Joints of Spine
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Joint Type

7. Global Joint Pain Injections Market Analysis and Forecast, by Injection Type

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Injection Type, 2017-2031
    • 7.3.1. Corticosteroid Injections
    • 7.3.2. Hyaluronic Acid Injections
    • 7.3.3. Others
  • 7.4. Market Attractiveness Analysis, by Injection Type

8. Global Joint Pain Injections Market Analysis and Forecast, by Distribution Channel

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 8.3.1. Hospital Pharmacies
    • 8.3.2. Online Pharmacies
    • 8.3.3. Retail Pharmacies
  • 8.4. Market Attractiveness Analysis, by Distribution Channel

9. Global Joint Pain Injections Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Joint Pain Injections Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Joint Type, 2017-2031
    • 10.2.1. Knee & Ankle
    • 10.2.2. Hip Joint
    • 10.2.3. Shoulder & Elbow
    • 10.2.4. Facet Joints of Spine
    • 10.2.5. Others
  • 10.3. Market Value Forecast, by Injection Type, 2017-2031
    • 10.3.1. Corticosteroid Injections
    • 10.3.2. Hyaluronic Acid Injections
    • 10.3.3. Others
  • 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.4.1. Hospital Pharmacies
    • 10.4.2. Online Pharmacies
    • 10.4.3. Retail Pharmacies
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Joint Type
    • 10.6.2. By Injection Type
    • 10.6.3. By Distribution Channel
    • 10.6.4. By Country

11. Europe Joint Pain Injections Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Joint Type, 2017-2031
    • 11.2.1. Knee & Ankle
    • 11.2.2. Hip Joint
    • 11.2.3. Shoulder & Elbow
    • 11.2.4. Facet Joints of Spine
    • 11.2.5. Others
  • 11.3. Market Value Forecast, by Injection Type, 2017-2031
    • 11.3.1. Corticosteroid Injections
    • 11.3.2. Hyaluronic Acid Injections
    • 11.3.3. Others
  • 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 11.4.1. Hospital Pharmacies
    • 11.4.2. Online Pharmacies
    • 11.4.3. Retail Pharmacies
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Joint Type
    • 11.6.2. By Injection Type
    • 11.6.3. By Distribution Channel
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Joint Pain Injections Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Joint Type, 2017-2031
    • 12.2.1. Knee & Ankle
    • 12.2.2. Hip Joint
    • 12.2.3. Shoulder & Elbow
    • 12.2.4. Facet Joints of Spine
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Injection Type, 2017-2031
    • 12.3.1. Corticosteroid Injections
    • 12.3.2. Hyaluronic Acid Injections
    • 12.3.3. Others
  • 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.4.1. Hospital Pharmacies
    • 12.4.2. Online Pharmacies
    • 12.4.3. Retail Pharmacies
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Joint Type
    • 12.6.2. By Injection Type
    • 12.6.3. By Distribution Channel
    • 12.6.4. By Country/Sub-region

13. Latin America Joint Pain Injections Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Joint Type, 2017-2031
    • 13.2.1. Knee & Ankle
    • 13.2.2. Hip Joint
    • 13.2.3. Shoulder & Elbow
    • 13.2.4. Facet Joints of Spine
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Injection Type, 2017-2031
    • 13.3.1. Corticosteroid Injections
    • 13.3.2. Hyaluronic Acid Injections
    • 13.3.3. Others
  • 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.4.1. Hospital Pharmacies
    • 13.4.2. Online Pharmacies
    • 13.4.3. Retail Pharmacies
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Joint Type
    • 13.6.2. By Injection Type
    • 13.6.3. By Distribution Channel
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Joint Pain Injections Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Joint Type, 2017-2031
    • 14.2.1. Knee & Ankle
    • 14.2.2. Hip Joint
    • 14.2.3. Shoulder & Elbow
    • 14.2.4. Facet Joints of Spine
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Injection Type, 2017-2031
    • 14.3.1. Corticosteroid Injections
    • 14.3.2. Hyaluronic Acid Injections
    • 14.3.3. Others
  • 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.4.1. Hospital Pharmacies
    • 14.4.2. Online Pharmacies
    • 14.4.3. Retail Pharmacies
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Joint Type
    • 14.6.2. By Injection Type
    • 14.6.3. By Distribution Channel
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2021
  • 15.3. Company Profiles
    • 15.3.1. Pfizer, Inc.
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Anika Therapeutics, Inc.
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. Bioventus
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Eli Lilly and Company
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. Ferring B.V.
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. Pacira BioSciences, Inc. (Flexion Therapeutics)
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. Sanofi
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Seikagaku Corporation
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. Zimmer Biomet
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments